#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Choroid melanoma Philadelphia chromosome positive Neuroendocrine tumour of the lung Complex regional pain syndrome Cytomegalovirus infection Aplastic anaemia Alveolar proteinosis NTRK gene fusion overexpression Ovarian epithelial cancer Ichthyosis Adenomatous polyposis coli Extra-osseous Ewing's sarcoma recurrent Langerhans' cell histiocytosis Sarcoma Central nervous system lymphoma More trials…

    Learn about Rare Diseases

    Kearns-Sayre syndrome Thrombotic thrombocytopenic purpura – Diagnostics Extranodal marginal zone B-cell lymphoma (MALT type) – Diagnostics Methylmalonic acidaemia – Diagnostics Leiomyosarcoma – Diagnostics Prader-Willi syndrome – Trials in Disease Hairy cell leukaemia – Basic Information Gastrointestinal stromal tumour Tuberous sclerosis complex – Diagnostics Primary mediastinal large B-cell lymphoma More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Bi 706321 PEGZILARGINASE Abc-15Bo-116 The-630 Dexmedetomidine Hydrochloride Dornase Alfa Menotrophin Aup1602-C Taletrectinib Triptorelin Acetate Inclisiran Brodalumab Folic Acid, Anhydrous Tofacitinib Oxymetazoline Hydrochloride Mecillinam GSKVX000000034797 Tramadol Hydrochloride Caraway Oil Specific Nucleic Acid Sna-Her2 More therapies…

    Learn about Your Condition

    Craniotomy Primary hyperthyroidism Ulcerative keratitis Depression Myositis Gastrectomy Paedophilia Cervix carcinoma stage II Right ventricular dysfunction Fatty acid oxidation disorder Glioblastoma multiforme Prolymphocytic leukaemia Vulvar dysplasia Acute hepatic failure Pulmonary fibrosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Graalum

  • Study on Ketamine and Midazolam for Adults with Depression and Alcohol Use Disorder

    Recruiting

    1 1 1
    Investigated Drugs:
    • Ketamine
    • Midazolam Hydrochloride
    Norway

  • Study Comparing MK-5684 with Abiraterone Acetate or Enzalutamide for Patients with Advanced Prostate Cancer After Hormonal Therapy and Chemotherapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hormone-refractory prostate cancer
    Investigated Drugs:
    • Prednisone Acetate
    • Fludrocortisone Acetate
    • Opevesostat Tosilate
    Austria Czechia Denmark Finland France Germany +8

  • Study on Lomustine and Temozolomide for Newly Diagnosed Glioblastoma Patients

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Temozolomide
    Austria Denmark Norway Sweden

  • Study on Clazakizumab for Heart Disease in Adults with End-Stage Kidney Disease on Dialysis

    Recruiting

    4 1
    Investigated Diseases:
    • Arteriosclerosis
    Investigated Drugs:
    • Clazakizumab
    Austria Belgium Bulgaria Croatia Czechia Denmark +16

  • Study of Hyperbaric Oxygen Therapy Combined with Standard Treatment for Patients with Sudden Hearing Loss

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Deafness neurosensory
    Investigated Drugs:
    • Nitrous Oxide
    • Oxygen
    Norway

  • Randomized Phase III trial of elecoglipron plus dapagliflozin on kidney outcomes and mortality in adults with chronic kidney disease

    Recruiting

    3 1 1
    Investigated Diseases:
    • Chronic kidney disease
    Investigated Drugs:
    • Azd5004
    • Dapagliflozin
    Bulgaria Czechia Denmark Finland France Germany +8
Previous Page
1 2 3 4 5 6 … 8
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Sodium Chloride Tenecteplase Apixaban Hydrocortisone Clopidogrel Prednisone Alteplase Nivolumab Acetylsalicylic Acid Asundexian Dexamethasone Pembrolizumab Cisplatin Placebo Enzalutamide Cloxacillin Doxorubicin Hydrochloride Lenalidomide Entecavir Gemcitabine Hydrochloride Dalteparin Sodium Nitrous Oxide Piperacillin Sodium Polatuzumab Vedotin Cortisone Ianalumab Povetacicept Oxygen Prednisolone Tazobactam Sodium Show more

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

Acute myocardial infarction Alcohol use disorder Amyotrophic lateral sclerosis Aortic valve stenosis Arteriosclerosis Atrial fibrillation Bladder cancer Cancer pain Cardiac failure chronic Cardiovascular disorder Cerebrovascular accident prophylaxis Chronic kidney disease Chronic obstructive pulmonary disease Cold type haemolytic anaemia Deafness neurosensory Depression Diffuse large B-cell lymphoma refractory Glioblastoma Hormone-refractory prostate cancer Hypertension IgA nephropathy Immune thrombocytopenia Iron deficiency Ischaemic stroke Labour induction Low anterior resection syndrome Lung disorder Major depression Malignant melanoma Metabolic dysfunction-associated steatohepatitis Metastatic neoplasm Migraine Monkeypox Non-alcoholic steatohepatitis Non-small cell lung cancer Non-small cell lung cancer metastatic Pancreatic carcinoma Plasma cell myeloma Pneumonia Primary adrenal insufficiency Pulmonary embolism Renal cell carcinoma Retinal artery occlusion Sepsis Substance use disorder Thrombosis prophylaxis Transient ischaemic attack Transitional cell carcinoma metastatic Type 2 diabetes mellitus Type IIa hyperlipidaemia Warm autoimmune haemolytic anaemia

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!